Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

A new surgical technique using vellus hair grafts effectively treated vitiligo without causing unwanted hair growth.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Alopecia areata may be caused by the immune system attacking hair follicles.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.